Phase 2 Achondroplasia Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study of TYRA-300 in Children With Achondroplasia: BEACH301
Achondroplasia
Tyra Biosciences, Inc92 enrolled15 locationsNCT06842355
Recruiting
Phase 2
A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.
Achondroplasia
Ascendis Pharma A/S24 enrolled5 locationsNCT06732895
Recruiting
Phase 2Phase 3
Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
Achondroplasia
BioMarin Pharmaceutical160 enrolled2 locationsNCT07441876
Recruiting
Phase 2
A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia
Achondroplasia
Ascendis Pharma A/S72 enrolled18 locationsNCT06079398
Recruiting
Phase 2
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
Achondroplasia
QED Therapeutics, a BridgeBio company77 enrolled13 locationsNCT07169279